S.998

Authorizes the President to enter into trade agreements to eliminate duties or other import restrictions on medical goods to enhance national.

The Medical Supply Chain Resiliency Act aims to authorize the President to negotiate trade agreements for the reciprocal elimination of duties or other import restrictions on medical goods. These agreements aim to improve the resilience of the U.S. medical supply chain, enhance supply chain security, diversify supplier networks, and eliminate trade barriers. The act outlines specific purposes, including promoting regulatory cooperation, increasing access to government procurement markets, and encouraging good regulatory practices.